Alonso Krangle LLP Evaluating Potential NuvaRing Lawsuit Claims as Merck Faces More than 950 NuvaRing Lawsuits

Share Article

According to Merck & Co., the company faces more than 950 NuvaRing side effects lawsuits alleging NuvaRing caused serious injuries, including blood clots, deep vein thrombosis, pulmonary embolism, heart attacks, strokes and wrongful death.

Alonso Krangle LLP - Fighting for victims of personal injury cases, defective drug and medical device litigation, construction site accidents, nursing home abuse, medical malpractice negligence, qui tam/whistleblower actions and consumer fraud cases.

Alonso Krangle LLP - Fighting for victims of personal injury cases, defective drug and medical device litigation, construction site accidents, nursing home abuse, medical malpractice , whistleblower

"We are committed to helping those women injured by the Nuvaring birth control device every step of the way. Having experience regarding lawsuits with other birth control types, we understand what you are going through and can answer your questions."

Attorneys Andres Alonso and David Krangle, founding partners of Alonso Krangle LLP, a national law firm focused on fighting for the rights of serious personal injury victims, are offering FREE consultations for NuvaRing blood clot lawsuit side effect claims on behalf of young women, who may have been injured by this birth control as Merck now faces over 950 NuvaRing lawsuits.

NuvaRing lawsuit side effect claims currently being evaluated by Alonso Krangle LLP include those involving:

"We are committed to helping those women injured by the Nuvaring birth control device every step of the way. Having experience regarding lawsuits with other birth control types, we understand what you are going through and can answer your questions." - David Krangle, Partner at Alonso Krangle LLP

According to Merck & Co.’s 10-K earnings statement report for the fiscal year 2011, the company currently faces more than 950 NuvaRing lawsuits alleging the hormonal birth control device caused serious injuries, including blood clots, deep vein thrombosis, pulmonary embolism, heart attacks, strokes, or wrongful death. According to the Merck & Co. report, which was released on February 28, 2012, 820 lawsuits are or will be pending in a multidistrict litigation before Rodney W. Sippel of the U.S. District Court, Eastern District of Missouri (MDL No. 1964). Roughly 125 additional lawsuits are pending in a Mass Tort proceeding in the Bergen County Superior Court of New Jersey, according to the report (Docket No. BER-L-3081-09). [merck.com/investors/financials/form-10-k-2011.pdf]

There is still time for young women who may have been injured by NuvaRing, or their families, to file personal injury lawsuits seeking compensation for medical bills, pain and suffering, emotional distress and other damages. To discuss a potential claim with one of the experienced and compassionate NuvaRing side effect lawyers at Alonso Krangle LLP, please contact us at 1-800-403-6191 or visit our website, http://www.FightForVictims.com

About NuvaRing
NuvaRing (etonogestrel/ethinyl estradiol vaginal ring) is a hormonal contraceptive device that releases a combination of etonogestrel, a synthetic generation progestin, and the estrogen, ethinyl estradiol. NuvaRing is a small flexible ring that is designed to be inserted into the vagina once a month. It is kept in place for three weeks, and prevents pregnancy by releasing controlled amounts of those hormones into the bloodstream. Marketed by Merck & Co.’s Organon subsidiary, NuvaRing was introduced to the U.S. marketplace in 2001.

Etonogestrel is a form of desogestrel, a third-generation progestin. In February 2007, the consumer advocacy group Public Citizen petitioned the U.S. Food & Drug Administration (FDA) to ban oral birth control pills that contain desogestrel, citing studies which indicated they could double the risk of blood clots compared to second generation oral contraceptives. Last October, the FDA published a study comparing different methods of hormonal birth control that found NuvaRing raised the risk of blood clots, including deep vein thrombosis and pulmonary embolism, by 56% when compared to older birth control pills. The FDA study noted that combined hormonal contraceptives, including the etonogestrel/ethinyl estradiol vaginal ring, “potentially result in higher sustained exposure to estrogen and hence, increased thromboembolic risk.” [citizen.org/notmypill; fda.gov/downloads/Drugs/DrugSafety/UCM277384.pdf]

Alonso Krangle LLP is now evaluating lawsuit claims stemming from possible NuvaRing side effects. To discuss your case with one of the experienced and compassionate NuvaRing side effect lawyers at Alonso Krangle LLP, please contact us at 1-800-403-6191 or visit our website, FightForVictims.com.

About Alonso Krangle LLP
Andres Alonso and David Krangle, attorneys with almost 40 years of collective legal experience, have focused their law practice on the handling of significant personal injury cases, defective drug and medical device litigation, construction site accidents, nursing home abuse, medical malpractice, whistleblower actions and consumer fraud cases. A national law firm representing injured victims throughout the U.S., Alonso Krangle LLP is headquartered in Long Island, New York, with offices in New York City, and plans to open additional locations in New Jersey.

For more information about Alonso Krangle or to join the fight and be a part of our team, please contact us at 1-800-403-6191 or visit our website, http://www.FightForVictims.com.

Contact:
Alonso Krangle LLP
445 Broad Hollow Road
Suite 205
Melville, New York 11747
Toll-FREE 1-800-403-6191
Tel: 516-350-5555
Fax: 516-350-5554

Share article on social media or email:

View article via:

Pdf Print

Contact Author

David Krangle

Andres Alonso
Visit website